FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

EW

Edwards LifesciencesNYSE · Health Care Equipment · Health Care
Previous close
89.28
Change
+3.54 / +4.13%
FinDog View
Neutral
52-Week Range
72.30 – 96.29
P/E (TTM)
51.2
Forward P/E
29.8
Based on consensus earnings for the next 12 months
Market Cap
$51.5B
1M
−1.68%
S&P 500 −2.41% over same period
Volume / Avg Volume
5.0M / 3.1M
1.60× average

Price History

Closing price · USD1M6M1Y5Y
708090100FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 51.71M6M1Y5Y
485052542026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-23$1.7B0.78 / 0.76−1.42%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-23$1.6B0.78 / 0.75+5.56%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-10—— / —+2.96%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-30—— / —−1.23%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-24—— / —+5.54%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-23—— / —+6.63%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 98 of its 5-year rangeExpensive
5-year range 10.2 – 47.9 · Median 31.5
Last 4 quarters: $1.2B in buybacks + $0 in dividends, 2.34% of market cap combined
P/E (TTM)
51.2
P/B
4.9
P/S
7.9
PEG
3.38
Earnings Reaction
Over the last 6 reports, the stock moved ±3.9% on average on the first trading day after, rising 4 times
Most recent −1.42%
Volatility & Correlation
1-year beta 0.56 · Correlation with S&P 500 0.28Low beta
Annualized volatility 25% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 11 · $4.6MNet selling $4.6M
  • 09-11Lippis Daniel J.CVP, TAVRSell$0.05M619 shares · Avg price 87.51
  • 08-31Dahl Andrew M.SVP, Corporate ControllerSell$0.05M544 shares · Avg price 91.06
  • 08-28Bruls AnnetteCVP, EMEACLASell$0.24M2,644 shares · Avg price 89.98
  • 08-26Markowitz WayneCVP, JAPACSell$0.11M1,240 shares · Avg price 91.47
  • 08-26Chopra DaveenCVP, TMTT, Surgical & IHFMSell$2.9M31,800 shares · 2 trades · Avg price 91.02
  • 08-11Lippis Daniel J.CVP, TAVRSell$0.06M619 shares · Avg price 92.03
  • 07-30Markowitz WayneCVP, JAPACSell$0.01M146.313 shares · Avg price 86.03
  • 07-28Markowitz WayneCVP, JAPACSell$0.82M9,628 shares · Avg price 85.06
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q21.74+13.6%77.5%0.510.240.590.42
FY2026 Q11.65+16.7%78.0%0.480.38-0.020.66
FY2025 Q41.57+13.3%78.1%0.150.090.350.16
FY2025 Q31.55+14.7%77.8%0.310.290.520.50
FY2025 Q21.53+11.9%77.5%0.410.330.240.56
FY2025 Q11.41+6.2%78.7%0.390.360.220.61
FY2024 Q41.39+9.4%——0.39-0.180.65
FY2024 Q31.35+8.9%80.6%0.353.070.305.13
FY2024 Q21.37+7.1%79.9%0.370.370.290.61
FY2024 Q11.33+8.9%78.4%0.350.35-0.120.58
FY2023 Q41.27+194.6%——0.370.050.61
FY2023 Q31.24−5.7%79.8%0.370.380.360.63

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
EWEdwards Lifesciences$51.5B51.2+13.6%77.5%−1.68%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare